Applied tariffs
Simple average MFN applied
2024
*
3.0 %
Trade-weighted MFN average
2024
*
1.0 %
Share of MFN duty-free
2024
90.1 %
Best preference trade-weighted average
2024
*
0.8 %
Bound tariffs
Simple average bound
*
7.7 %
Binding coverage
99.7 %
Share of bound duty-free
20.8 %
Imports
Total imports: 369,424.1 million USD in 2024
Imports by partner
European Union
52.8 %
195,099.3
million USD
United States of America
7.9 %
29,331.1
million USD
China
5.5 %
20,320.8
million USD
United Arab Emirates
3.5 %
13,077.7
million USD
United Kingdom
2.3 %
8,522.1
million USD
Canada
2.3 %
8,491.6
million USD
Japan
2.1 %
7,830.3
million USD
Uzbekistan
1.7 %
6,112.4
million USD
Hong Kong, China
1.6 %
5,861.6
million USD
Australia
1.3 %
4,748.5
million USD
Rest of the World
19.0 %
70,028.8
million USD
Imports by products HS 2022
710812
Gold, incl. gold plated with platinum, unwrought, for non-monetary purposes (excl. gold in powder form)
28.2 %
104,152.9
million USD
300490
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
11.6 %
42,778.9
million USD
300215
Immunological products, put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents)
2.8 %
10,524.7
million USD
711319
Articles of jewellery and parts thereof, of precious metal other than silver, whether or not plated or clad with precious metal (excl. articles > 100 years old)
2.4 %
8,997.1
million USD
300212
Antisera and other blood fractions
1.4 %
5,156.4
million USD
271019
Medium oils and preparations, of petroleum or bituminous minerals, not containing biodiesel, n.e.s.
1.1 %
4,176.8
million USD
300439
Medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues)
0.9 %
3,189.3
million USD
300214
Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents)
0.7 %
2,607.1
million USD
711291
Waste and scrap of gold, incl. metal clad with gold, and other waste and scrap containing gold or gold compounds, of a kind used principally for the recovery of precious metal (excl. ash, and waste and scrap of gold melted down into unworked blocks, ingots, or similar forms, and sweepings containing other precious metals, and e-waste of heading 8549)
0.7 %
2,505.6
million USD
870340
Motor cars and other motor vehicles principally designed for the transport of <10 persons, incl. station wagons and racing cars, with both spark-ignition internal combustion reciprocating piston engine and electric motor as motors for propulsion (excl. vehicles for travelling on snow, other specially designed vehicles of subheading 8703.10 and plug-in hybrids)
0.7 %
2,464.7
million USD
Rest of the products
49.5 %
182,870.6
million USD
Exports
Total exports: 446,648.2 million USD in 2024
Exports by destination
European Union
40.5 %
180,744.3
million USD
United States of America
16.5 %
73,536.7
million USD
China
9.5 %
42,329.9
million USD
India
5.1 %
22,612.7
million USD
United Kingdom
5.0 %
22,537.2
million USD
Hong Kong, China
2.8 %
12,287.1
million USD
United Arab Emirates
2.5 %
11,351.8
million USD
Japan
2.1 %
9,266.4
million USD
Türkiye
2.0 %
9,092.5
million USD
Saudi Arabia, Kingdom of
1.6 %
7,310.3
million USD
Rest of the World
12.4 %
55,579.4
million USD
Exports by products HS 2022
710812
Gold, incl. gold plated with platinum, unwrought, for non-monetary purposes (excl. gold in powder form)
23.8 %
106,435.2
million USD
300215
Immunological products, put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents)
11.5 %
51,212.4
million USD
300490
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits)
10.0 %
44,621.9
million USD
293399
Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, and lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl loflazepate "INN", fludiazepam "INN", flunitrazepam "INN", flurazepam "INN", halazepam "INN", lorazepam "INN", lormetazepam "INN", mazindol "INN", medazepam "INN", midazolam "INN", nimetazepam "INN", nitrazepam "INN", nordazepam "INN", oxazepam "INN", pinazepam "INN", prazepam "INN", pyrovalerone "INN", temazepam "INN", tetrazepam "INN" and triazolam "INN", salts thereof and azinphos-methyl "ISO")
4.0 %
17,667.7
million USD
910221
Wrist-watches, whether or not incorporating a stop-watch facility, with automatic winding (excl. of precious metal or of metal clad with precious metal)
3.0 %
13,558.4
million USD
711319
Articles of jewellery and parts thereof, of precious metal other than silver, whether or not plated or clad with precious metal (excl. articles > 100 years old)
3.0 %
13,446.8
million USD
293359
Heterocyclic compounds with nitrogen hetero-atom[s] only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqualone "INN" and zipeprol "INN", and salts thereof)
2.2 %
10,015.6
million USD
710813
Gold, incl. gold plated with platinum, in semi-manufactured forms, for non-monetary purposes
2.2 %
9,889.0
million USD
910121
Wrist-watches of precious metal or of metal clad with precious metal, whether or not incorporating a stop-watch facility, with automatic winding (excl. with backs made of steel)
1.7 %
7,814.9
million USD
300212
Antisera and other blood fractions
1.0 %
4,424.7
million USD
Rest of the products
37.5 %
167,561.6
million USD
Preferential regimes provided by Switzerland
Loading...
Switzerland as a beneficiary based on other economies reported preferential regimes
Loading...